MedPath

Sodium bicarbonate

Generic Name
Sodium bicarbonate
Brand Names
Alka-seltzer, Alka-seltzer Fruit Chews, Alka-seltzer Heartburn Relief, Bi-peglyte, Bibag, Bicart, Bss Ophthalmic Solution, Ceo-two, Colyte, Gavilyte-C, Gavilyte-G, Gavilyte-H and Bisacodyl, Gavilyte-N, Golytely, H.E.L.P.bicel, Hema Bp-38, Hemacart, Konvomep, Nulytely, Peglyte, Phoxillum, Physioneal 40, Prismasol, Zegerid, Zegerid Reformulated Aug 2006, Zegerid With Magnesium Hydroxide
Drug Type
Small Molecule
Chemical Formula
CHNaO3
CAS Number
144-55-8
Unique Ingredient Identifier
8MDF5V39QO
Background

Sodium bicarbonate is a white, crystalline powder that is commonly used as a pH buffering agent, an electrolyte replenisher, systemic alkalizer and in topical cleansing solutions.

Indication

Sodium bicarbonate is used for the treatment of metabolic acidosis which may occur in severe renal disease, uncontrolled diabetes, circulatory insufficiency due to shock or severe dehydration, extracorporeal circulation of blood, cardiac arrest and severe primary lactic acidosis. Also is indicated in severe diarrhea which is often accompanied by a significant loss of bicarbonate. Further indicated in the treatment of certain drug intoxications, including barbiturates (where dissociation of the barbiturateprotein complex is desired), in poisoning by salicylates or methyl alcohol and in hemolytic reactions requiring alkalinization of the urine to diminish nephrotoxicity of blood pigments.

Associated Conditions
Barbiturate intoxication, Breast Cancer, Constipation, Dental Decay, Duodenal Ulcer, Dyspepsia, Gastro-esophageal Reflux Disease (GERD), Gingival Bleeding, Heartburn, Helicobacter Infections, Hyperkalemia, Ischaemia, Metabolic Acidosis, Myocardial Infarction, Plaque, Dental, Pruritis of the skin, Skin Irritation, Upper GI Bleeding, Upset stomach, Zollinger-Ellison Syndrome, Abdominal bloating, Benign, active Gastric Ulcer, Methyl alcohol poisoning, Prophylaxis of Contrast-induced nephropathy, Salicylate poisoning, Severe Diarrhea, Swelling of the gums
Associated Therapies
Bowel preparation therapy

Effect of Sodium Bicarbonate Buccal Infiltration on the Success of Inferior Alveolar Nerve Block

Phase 3
Completed
Conditions
Local Anesthesia
Interventions
Drug: sterile distilled water
First Posted Date
2016-04-04
Last Posted Date
2016-04-05
Lead Sponsor
Masoud Saatchi
Target Recruit Count
100
Registration Number
NCT02726737
Locations
🇮🇷

Isfahan University of Medical Sciences, Isfahan, Iran, Islamic Republic of

Optimal Lidocaine Buffering to Reduce Injection Pain in Local Anesthesia

Phase 4
Terminated
Conditions
Local Anesthesia
Interventions
First Posted Date
2016-01-06
Last Posted Date
2023-08-21
Lead Sponsor
University of Nebraska
Target Recruit Count
70
Registration Number
NCT02647892
Locations
🇺🇸

University of Nebraska Medical Center, Omaha, Nebraska, United States

Laser Ablation Versus Mechanochemical Ablation Trial

Phase 4
Completed
Conditions
Varicose Veins
Interventions
First Posted Date
2015-12-11
Last Posted Date
2023-09-21
Lead Sponsor
Hull University Teaching Hospitals NHS Trust
Target Recruit Count
150
Registration Number
NCT02627846
Locations
🇬🇧

Hull and East Yorkshire Hospitals NHS Trust, Hull, United Kingdom

Extended Use of Sodium Bicarbonate in Patients With Cancer

Phase 1
Completed
Conditions
Malignant Neoplasm
Interventions
First Posted Date
2015-08-25
Last Posted Date
2016-04-13
Lead Sponsor
University of Arizona
Target Recruit Count
15
Registration Number
NCT02531919
Locations
🇺🇸

University of Arizona Medical Center-University Campus, Tucson, Arizona, United States

Effect of Urinary Alkalinization on Urine Uric Acid Precipitation and Crystallization in Adults With Type 1 Diabetes

Phase 4
Completed
Conditions
Diabetic Nephropathy
Diabetic Kidney Disease
Type 1 Diabetes
Interventions
First Posted Date
2015-07-20
Last Posted Date
2022-01-24
Lead Sponsor
University of Colorado, Denver
Target Recruit Count
45
Registration Number
NCT02502071
Locations
🇺🇸

Barbara Davis Center for Diabetes, Aurora, Colorado, United States

NAC, NaHCO3 and NS Prophylaxis for CTPA in the ED on Suspicion of PE: A Randomized Controlled Trial

Phase 4
Completed
Conditions
Radiographic Contrast Agent Nephropathy
Pulmonary Embolism
Interventions
Drug: Normal Saline
First Posted Date
2015-06-26
Last Posted Date
2015-06-26
Lead Sponsor
Karadeniz Technical University
Target Recruit Count
231
Registration Number
NCT02483143
Locations
🇹🇷

Karadeniz Technical University Faculty of Medicine, Trabzon, Turkey

Sodium Bicarbonate to Treat Severe Acidosis in the Critically Ill

Phase 3
Completed
Conditions
Metabolic Acidosis
Interventions
First Posted Date
2015-06-19
Last Posted Date
2024-05-29
Lead Sponsor
University Hospital, Montpellier
Target Recruit Count
400
Registration Number
NCT02476253
Locations
🇫🇷

DAR St Eloi, Montpellier, France

Acid-Base Compensation in Chronic Kidney Disease

Phase 1
Completed
Conditions
Chronic Kidney Disease
Interventions
Other: Controlled diet
First Posted Date
2015-04-28
Last Posted Date
2017-08-30
Lead Sponsor
Duke University
Target Recruit Count
14
Registration Number
NCT02427594
Locations
🇺🇸

Duke University School of Medicine, Durham, North Carolina, United States

Sympatholysis in Chronic Kidney Disease

Phase 1
Recruiting
Conditions
Chronic Kidney Disease
Interventions
Drug: Placebo
Behavioral: Exercise Training
Behavioral: Control to Exercise (Stretching)
First Posted Date
2015-04-08
Last Posted Date
2025-03-05
Lead Sponsor
Emory University
Target Recruit Count
110
Registration Number
NCT02411773
Locations
🇺🇸

Atlanta VA Medical Center, Decatur, Georgia, United States

Bicarbonate in Patients With Out-of-hospital Cardiac Arrest

Phase 2
Completed
Conditions
Cardiac Arrest
Metabolic Acidosis
Interventions
Drug: Normal saline
First Posted Date
2014-12-01
Last Posted Date
2022-03-25
Lead Sponsor
Asan Medical Center
Target Recruit Count
50
Registration Number
NCT02303548
© Copyright 2025. All Rights Reserved by MedPath